Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.

• Status: Completed
• Trial end date: 2009-12-01

Summary

The purpose of this study is to determine the efficacy and safety of Peginesatide Injection for the maintenance of anemia in patients with chronic renal failure who are on hemodialysis or do not require dialysis and who were previously treated with Darbepoetin Alfa.

• Phase: Phase 2

Details

• Lead Sponsor: Takeda
• Collaborator: Affymax
• Treatments: Darbepoetin alfa